NCT00004842View on ClinicalTrials.gov

Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis

PHASE1CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

May 31, 1997

Primary Completion Date

April 30, 1999

Study Completion Date

April 30, 1999

Conditions

Cholangitis, SclerosingLiver Cirrhosis, Biliary

Interventions

DRUG

budesonide

Oral budesonide, 9 mg daily was administered for 1 year

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Mayo Clinic

OTHER

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH